Janone to present at the dawson james 8th annual investment conference

Chief medical officer dr. amol soin will explain innovative approaches to pain management and janone's development of non-addicting treatments for pain las vegas , sept. 21, 2023 /prnewswire/ -- janone (nasdaq: jan), the biopharmaceutical company focused on developing non-addicting painkillers and novel treatments for the causes of pain, will participate in investor sessions at the dawson james securities 8th annual investment conference in jupiter, florida.
JAN Ratings Summary
JAN Quant Ranking